Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kaletra
Asia
Chloroquine, BeiGene, Merck KGaA and more—FiercePharmaAsia
Chloroquine fails in China study, as India bans its export. China halts BeiGene's Abraxane supply. MET inhibitor Tepmetko wins first global nod.
Angus Liu
Mar 27, 2020 10:56am
Chloroquine, Kaletra and a flu drug disappoint in COVID-19 tests
Mar 24, 2020 11:40am
AbbVie gives up Kaletra rights amid COVID-19 tests: report
Mar 23, 2020 3:05pm
Biogen, Bayer rogue staffers; Kaletra and more—FiercePharmaAsia
Mar 20, 2020 10:10am
AbbVie's HIV drug Kaletra fails in COVID-19 trial—or does it?
Mar 19, 2020 10:59am
J&J warns doctors off using HIV med Prezista for COVID-19
Mar 17, 2020 11:51am
